Article
Glioblastoma--a moving target.
Upsala journal of medical sciences - 1 May 2012
Westermark Bengt
Abstract excerpt
The slow development of effective treatment of glioblastoma is contrasted by the rapidly advancing research on the molecular mechanisms underlying the disease. Amplification and overexpression of receptor tyrosine kinases, particularly EGFR and PDGFRA, are complemented by mutations in the PI3K, RB1, and p53 signaling pathways. In addition to finding effective means to target these pathways, we may take advantage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
